International Society for Heart and Lung Transplantation (ISHLT)

The #ISHLT is honored to announce Robert L. Kormos, MD, FRCS(C), FACS as the 2026 Amanda W. Rowe Distinguished Service Award recipient, which recognizes outstanding contributions to the Society. 🎉 Dr. Kormos will be recognized at #ISHLT2026.

Learn more about his contributions at 🔗 bit.ly/4kAEGiw

El próximo mes, #ISHLTenEspañol ofrecerá este webinar tiene como propósito discutir la evaluación de trasplante para pacientes con hipertensión pulmonar. 🖥️💡 El evento es completamente gratuito y todos están invitados a participar.

▶️ Más información e inscripción en 🔗 https://bit.ly/4qNG4R2

Did you know #ISHLTMembers get the best rates to #ISHLT2026? 💸 Join now to save on the meeting of the year + enjoy all other member benefits. ➡️ Sign up today: 🔗 www.ishlt.org/membership

#TransplantSky

#CEoT2026 is this month in Scottsdale, AZ USA. 💡 Register to explore emerging technologies, allocation strategies, and innovations shaping the future of #transplant care: 🔗 https://bit.ly/49rPgTQ

Grants for Lung and Heart Transplant Research Co-funded by the ISHLT and ISHLT Foundation ISHLT announced over $257,000 USD in funding for research designed to improve care for patients with advanced heart and lung disease. These funds were provided by the ISHLT Foundation.

Learn more about his work at 🔗 bit.ly/4qCGObN

#ISHLTResearchGrant #CardiogenicShock #TissuePerfusion #PatientCare

#ISHLT awarded the Cardiogenic Shock Research Grant, supported by Johnson & Johnson MedTech | Heart Recovery, to Benjamin Steinhorn, MD, PhD of Massachusetts General Hospital. 🎉 Dr. Steinhorn's study aims to determine the effectiveness of tissue perfusion pressure measurement for patient care. 🫀

YouTube video by ISHLT Headquarters ISHLTv Webinar - Difficult Donor Dilemmas in Thoracic Transplant (2 February, 2026)

Free to share - great discussion recently hosted by @ishlt.bsky.social and the Infectious Diseases professional community, evaluating risks and management of donor-derived infections.

Special thanks to @mady247.bsky.social from duke for organizing and all our speakers 🙏

youtu.be/hKGczPYJea8

LAST CALL: Support #ISHLT2026 to connect with medical professionals from the global #transplant community. 📆⏰ Submit an application by Friday, 6 February to claim an opportunity. Act now at 🔗 https://bit.ly/3CGlO03

It’s the LAST DAY to claim early bird pricing for #ISHLT2026 registration! Don't miss out on the meeting of the year - connect and collaborate with your global colleagues in Toronto. 👋 Register & save now: 🔗 https://bit.ly/3VF9h38

Pharmacy in Heart and Lung Transplant: The Latest Studies in ISHLT Journal Watch The first Journal Watch of 2026 explores topics in transplant pharmacy, including valganciclovir for CMV, daratumumab monotherapy, and renal sparing in heart transplant recipients.

The January #ISHLTJournalWatch focuses on topics in #transplant #pharmacy, edited by Colleen Hutchinson. 💊

Topics include the NUDT16 genotype, #daratumumab monotherapy, & early mammalian target of rapamycin inhibitor (#mTORi).

🔗 www.ishlt.org/about/news-d...

#TransplantSky #PharmSky

ISHLT Standards & Guidelines 2025 Year in Review ISHLT develops Professional Guidelines and Consensus Documents regarding professional practice matters and the care of patients with advanced heart and/or lung disease. In 2025, ISHLT published eight ...

Check out the latest #ISHLT Standards & Guidelines documents. 8️⃣ were published last year, engaging 169 experts from around the globe. 🌍 Learn more at 🔗 bit.ly/49NdOqt

#TransplantSky #MedSky

The #ISHLT is honored to announce John Dark, MB, FRCS as the 2026 Lifetime Achievement Award recipient, the Society's highest honor. 🎉 Professor Dark will be recognized at #ISHLT2026. Learn more about the award and Professor Dark's contributions to the field at 🔗 https://bit.ly/4t7fjZl

📌 Webinar de #ISHLTenEspañol: Consideraciones Médicas, Quirúrgicas, y Anestésicas en el Trasplante para Hipertensión Pulmonar Arterial
🗓️ 11 de Marzo
🔗 Ver el programa y regístrate ahora: https://bit.ly/4qNG4R2

#MedSky #TransplantSky #PAH

You're invited to #ISHLT2026! Registration includes:

✅Admission to all general & scientific sessions
✅Gather and mingle at a variety of networking events
✅Access to the poster hall
✅Meet industry experts in the exhibit hall

Register by 4 February to save: 🔗 https://bit.ly/4aFzxTd

#TransplantSky

#ISHLT awarded International Visiting Scholarships to 5️⃣ recipients. 🌎 These funds facilitate the exchange of knowledge and techniques for the treatment of end-stage heart and lung failure and transplantation. Congratulations to the recipients! 🎉🫀🫁

Learn more about their plans at 🔗 bit.ly/4ah02xN

Pharmacy in Heart and Lung Transplant: The Latest Studies in ISHLT Journal Watch The first Journal Watch of 2026 explores topics in transplant pharmacy, including valganciclovir for CMV, daratumumab monotherapy, and renal sparing in heart transplant recipients.

The January #ISHLTJournalWatch focuses on topics in #transplant #pharmacy, edited by Colleen Hutchinson. 💊

Topics include the NUDT16 genotype, #daratumumab monotherapy, & early mammalian target of rapamycin inhibitor (#mTORi).

🔗 www.ishlt.org/about/news-d...

#TransplantSky #PharmSky

#ISHLT announced $257,000 USD in grants funded by the #ISHLTFoundation. These grants fund research in #CardiogenicShock, ex-vivo lung perfusion (#EVLP), and #AI #biomarkers in #LungTx. Congratulations to the grant recipients! 🎉🫀🫁

Learn more about their work at 🔗 https://bit.ly/4qCGObN

In 2025, #ISHLT published 8️⃣ documents regarding professional practice matters and the care of patients with advanced heart and/or lung disease. The Standards & Guidelines program engaged 169 total participants. 💡📚🌎

➡️ Check out the latest documents at 🔗 bit.ly/49NdOqt

#TransplantSky #MedSky

Join ISHLT's #PVD #InterdisciplinaryNetwork next week for a discussion on managing critically ill patients with #PVD. 🖥️💡

➡️ View the program + register: https://bit.ly/4pDzNXE

#MedSky #TransplantSky

Support #ISHLT this year. Share your latest updates, products, + services through ⤵️
📩 Newsletters
🖥️ Webinars
🎧 Podcasts

➡️ Establish your organization as a thought leader + sign up today: 🔗 https://bit.ly/3OHTL30

🚨 #CallforPapers: Submit your papers on Primary Graft Dysfunction (PGD) in thoracic organ #transplantation to @jhlt.bsky.social. 🫀🫁 Submissions will be accepted until 📆 28 February: 🔗 bit.ly/4r6vuog

#PGD #JHLT #TransplantSky #MedSky

Registered for #ISHLT2026? ✈️ Finish making your travel plans to Toronto. Learn more about important travel information and exclusive hotel booking for ISHLT2026 attendees at 🔗 https://bit.ly/43mMNYq

📢 LAST CALL for #ISHLTResearchGrants submissions:
🫀🫁 #ECPimmunomodulation in #CardiothoracicTx
🧒 Innovations in #pediatric #HeartTx⠀
🤖 Using molecular #biomarkers + #AI in HTx⠀
💡 Support for trainee #researchers⠀
⏰Apply by THIS Tuesday, 20 January at 11:59 p.m. ET: 🔗 https://bit.ly/4pGMjok

Connect with your global colleagues – #ISHLTconnect is open to anyone involved in managing and treating advanced #heart and #lung disease. 🫀🫁 Log in today at 🔗 https://bit.ly/4a8qPcU

Hear about game-changing #ISHLT moments from ISHLT leaders and community members. 🫀🫁🎯

#TransplantSky #MedSky

📣The #ISHLT2026 Final Program is now available! 📖 This year's sessions highlight the multidisciplinary, collaborative nature of #ISHLT, displaying the latest scientific advances and innovative research. 🫀🫁 Explore the selected symposia and abstracts at 🔗 https://bit.ly/4qneJVE

#MedSky

LAST CALL to apply to be a #RovingReporter at #ISHLT2026 in Toronto! 📲 Create and publish content about the latest scientific findings and meeting highlights and receive free registration plus ISHLT shoutouts. ⏰ Apply by this Friday: 🔗 https://bit.ly/4aTJFrR

#TransplantSky #MedSky

The fourth slide of December 2025's ISHLT Journal Watch, reviewing the study "CD26/DPP-IV inhibitors and associations with chronic lung allograft dysfunction in a multicenter cohort." A more screenreader friendly version of the issue can be found at https://www.ishlt.org/docs/default-source/journal-watch/202512_journalwatch_pulm_dec2025.pdf

December's #ISHLTJournalWatch closes with Zsofia Rosselli's review of a manuscript from @jhlt.bsky.social on whether gliptins can moderate #CLAD. This multicenter cohort implies association, but requires further study.

#pulmsky #ISHLT #medsky #pharmsky

📢 It's the FINAL WEEK to submit applications to 4️⃣ #ISHLTResearchGrants.⠀⠀
⏰ Submit by 20 January at 11:59 p.m. ET / 21 January at 03:59 UTC⠀⠀
📖 Learn more and apply at 🔗 https://bit.ly/4p6WX8f

#ECPImmunmodulation #PedsTx #HeartTx #LungTx #research #MedSky #TransplantSky

Cutting Edge of Transplantation (CEoT) 2026 Join the American Society of Transplantation at CEoT 2026, a three-day meeting focused on advancing transplantation science, clinical practice, and patient outcomes.

Join @astinfo.bsky.social at #CEoT2026. 💡 Explore emerging technologies, allocation strategies, and innovations shaping the future of #transplant care.

📅 26-28 February | 📍Scottsdale, AZ USA
🔗 Learn more at bit.ly/49rPgTQ